From the publishers of JADPRO

Metastatic Triple-Negative Breast Cancer Resource Center

Advertisement

Managing Adverse Events of Immunotherapy in Breast Cancer

Last Updated: Friday, January 13, 2023

Hatem Soliman, MD, Associate Member of Breast Oncology and Immunology and Medical Director of the Clinical Trials Office at Moffitt Cancer Center, answers questions on the most common adverse events associated with immunotherapy, how to address them, and whether immune-related adverse events predict response to treatment.

Clinical Advances in Hematology & Oncology
Advertisement
News & Literature Highlights
Advertisement
Advertisement